Saturday, July 16, 2011
Drug companies losing interest in psychiatry is great news
Letter from Sami Timimi in response to BMJ news article about drug companies pulling out of neuroscience research. I've mentioned in a previous post that I'm not sure if this is really the case. But if it is, as Sami points out, that's a good thing - we shouldn't be defensive about it. Psychiatry research has for too long been dependent on drug company sponsorship. The biomedical myth has been used as the justification for too much psychiatry research in general.
Subscribe to: Post Comments (Atom)
Agree entirely. The departure of big pharma from psychiatric drug R&D might be a "saving grace" for psychiatrists who truly care for their patients and look for every possible way to do so.
Miracles sometimes do happen—even if not for the "right" reason(s)…
Post a Comment